(Q38290355)

1 September 2017

title

Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics (English)

1 reference

1 September 2017

1 reference

Jose A Garcia-Sanz

6

0 references

author name string

Annabelle Grolleau

1

1 reference

1 September 2017

Jessica Bowman

2

1 reference

1 September 2017

Bérengère Pradet-Balade

3

1 reference

1 September 2017

Eric Puravs

4

1 reference

1 September 2017

Samir Hanash

5

1 reference

1 September 2017

Laura Beretta

7

1 reference

1 September 2017

language of work or name

English

0 references

publication date

9 April 2002

1 reference

Journal of Biological Chemistry

1 September 2017

published in

1 reference

1 September 2017

volume

277

1 reference

1 September 2017

issue

25

1 reference

1 September 2017

page(s)

22175-22184

1 reference

describes a project that uses

1 September 2017

1 reference

Rapamycin in transplantation: a review of the evidence

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Promising new agents in the prevention of transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Sirolimus: continuing the evolution of transplant immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

New treatment possibilities in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Rapamycin: FK506's fraternal twin or distant cousin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

TOR, a central controller of cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

PHAS-I as a link between mitogen-activated protein kinase and translation initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Messenger RNA translation state: the second dimension of high-throughput expression screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Isolation of translationally controlled mRNAs by differential screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

A two-dimensional electrophoresis-related laboratory information processing system: Spot matching

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Data base analysis of protein expression patterns during T-cell ontogeny and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Rapamycin inhibits proteasome activator expression and proteasome activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

The proteasome regulates receptor-mediated endocytosis of interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Involvement of proteasomes in regulating Jak-STAT pathways upon interleukin-2 stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Proteasome activity is required for T lymphocyte aggregation after mitogen activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Identification and characterization of a novel cell cycle-regulated internal ribosome entry site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Cap-dependent and cap-independent translation by internal initiation of mRNAs in cell extracts prepared from Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

BIN1 is a novel MYC-interacting protein with features of a tumour suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

CENP-E as an essential component of the mitotic checkpoint in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

SC35-mediated reconstitution of splicing in U2AF-depleted nuclear extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M202014200

Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.28.727

Identifiers

DOI

10.1074/JBC.M202014200

1 reference

1 September 2017

1 reference